NY-JEFFERIES-FINANCIAL
28.5.2020 18:04:07 CEST | Business Wire | Press release
Jefferies announced today a total donation to over 85 different charities of $9.25 million as a result of a firmwide global effort to raise money to honor the memory of their late CFO Peg Broadbent, who was a victim of this terrible disease.
Through the firm’s Global Coronavirus Relief Charity Day held May 27th, Jefferies’ clients helped to generate $7.65 million in donated net trading commissions. In addition, Jefferies as a firm will donate $1 million directly, and voluntary donations from Jefferies’ 3,822 employees totaled $600,000.
“We could not be prouder of our entire Jefferies family for raising $9.25 million and are greatly appreciative of the incredible partnership our clients have shown us in supporting our fight against Covid-19. The full $9.25 million will be wired today and go to direct relief efforts at over 85 worthy global charities who are each in the front lines helping those most impacted by the Coronavirus global pandemic. We went broadly to a large number of charities globally as this is truly a tragedy that affects all of us and, in particular, those who are most disadvantaged and in the greatest need.
The charities selected are both big and small and represent everything from food banks, child care services, assistance with PPE and other medical supplies, support for front line medical workers, assistance for afflicted military personnel, local teen centers, support for police and fire, workforce training and re-training and many other worthy areas that are most in need. We thank our employees and clients for aiding in the selection of many of these remarkable charities.
Finally, all of us at Jefferies would like to thank all the dedicated professionals working tirelessly on the front line to help those in need. They are the true heroes whom we are honored to help in Peg’s name.”
Contributions in the following amounts will be immediately distributed to these respected organizations:
NYC Mayor’s Fund | Peg’s Cure |
|
$ 150,000 |
All Hands and Hearts |
|
$ 150,000 |
American Heart Association |
$ 150,000 |
|
Bowery Mission |
$ 150,000 |
|
Hackensack Meridian Health Foundation |
$ 150,000 |
|
Houston Police Foundation |
|
$ 150,000 |
International Rescue Committee |
|
$ 150,000 |
Robin Hood Foundation |
|
$ 150,000 |
Strive |
|
$ 150,000 |
The Bass Foundation |
|
$ 150,000 |
World Central Kitchen |
|
$ 150,000 |
We Can #TogetherFromHome |
|
$ 100,000 |
Achievement First |
|
$ 100,000 |
Aktion Deutschland Hilft |
|
$ 100,000 |
Alzheimer’s Association |
|
$ 100,000 |
Ambitious About Autism |
|
$ 100,000 |
Barnardo’s |
$ 100,000 |
|
BMS Family Health and Wellness Center |
|
$ 100,000 |
Bob Woodruff Foundation |
|
$ 100,000 |
Boys & Girls Clubs of the Austin Area |
|
$ 100,000 |
Brewers Community Foundation |
|
$ 100,000 |
Buttle UK |
|
$ 100,000 |
Central Texas Food Bank |
|
$ 100,000 |
Chelsea and Westminster Hospital NHS Foundation Trust |
|
$ 100,000 |
Chrysalis |
$ 100,000 |
|
City Harvest |
$ 100,000 |
|
Citymeals on Wheels |
|
$ 100,000 |
Columbia Children's Hospital |
|
$ 100,000 |
Community Food Bank of New Jersey |
|
$ 100,000 |
Covenant House |
|
$ 100,000 |
Doctors Without Borders |
|
$ 100,000 |
East High – EOP (Education Partnership Organization) |
|
$ 100,000 |
Elmhurst Hospital Charity |
|
$ 100,000 |
Family Promise of Bergen County |
|
$ 100,000 |
FarmLink |
|
$ 100,000 |
Feeding America |
|
$ 100,000 |
Food Bank For New York City |
|
$ 100,000 |
Foodlink |
|
$ 100,000 |
Habitat for Humanity Japan |
|
$ 100,000 |
Hance Family Foundation |
|
$ 100,000 |
Humanity & Inclusion |
|
$ 100,000 |
Hunger Free America |
|
$ 100,000 |
Imperial Health Charity |
|
$ 100,000 |
Kids in Crisis |
|
$ 100,000 |
Kohka Foundation |
|
$ 100,000 |
Lahey Clinic Foundation |
|
$ 100,000 |
Mail Force Charity |
|
$ 100,000 |
Martha’s Table |
|
$ 100,000 |
Médecins Sans Frontières |
|
$ 100,000 |
Memorial Hermann Foundation |
|
$ 100,000 |
My Sister's Place |
|
$ 100,000 |
National Emergencies Trust |
|
$ 100,000 |
Navajo Nation Covid-19 Relief Fund |
|
$ 100,000 |
Nazareth Housing |
|
$ 100,000 |
Neighbourly Community Fund |
|
$ 100,000 |
NHS Charities Together |
|
$ 100,000 |
Northwell Health's COVID-19 Emergency Fund |
|
$ 100,000 |
NYU Langone |
|
$ 100,000 |
Off Their Plate |
|
$ 100,000 |
Oxfam India |
|
$ 100,000 |
Philippine Disaster Resilience Foundation |
|
$ 100,000 |
Red Hook Initiative |
|
$ 100,000 |
Rosetree Trust |
|
$ 100,000 |
Royal College of Nursing Foundation |
|
$ 100,000 |
RVNAhealth |
|
$ 100,000 |
Second Harvest |
|
$ 100,000 |
Sempre Con Voi (Always with You) |
|
$ 100,000 |
St Michael’s House |
|
$ 100,000 |
TBD 1 |
|
$ 100,000 |
TBD 2 |
|
$ 100,000 |
TBD 3 |
|
$ 100,000 |
TCF Bank |
|
$ 100,000 |
The Care Workers Charity |
|
$ 100,000 |
The River Fund New York |
|
$ 100,000 |
The United Way of Central Indiana COVID-19 Relief Fund |
|
$ 100,000 |
The World Health Organization (WHO) |
|
$ 100,000 |
Trinity's Services & Food for the Homeless |
|
$ 100,000 |
The Trussell Trust |
|
$ 100,000 |
UNICEF |
|
$ 100,000 |
UR Medicine Home Care’s Meals on Wheels |
|
$ 100,000 |
URMC COVID-19 Emergency Fund |
|
$ 100,000 |
Valpo Surf Project, Inc. |
|
$ 100,000 |
Volunteers of Legal Service |
|
$ 100,000 |
Our Dream Their Smile |
|
$ 100,000 |
West Side Campaign Against Hunger |
|
$ 100,000 |
Women United in Philanthropy |
|
$ 100,000 |
Women's Center of Greater Danbury |
|
$ 100,000 |
|
|
|
Jefferies Group LLC is the largest independent, global, full-service investment banking firm headquartered in the U.S. Focused on serving clients for nearly 60 years, Jefferies is a leader in providing insight, expertise and execution to investors, companies and governments. Our firm provides a full range of investment banking, advisory, sales and trading, research and wealth management services across all products in the Americas, Europe and Asia. Jefferies Group LLC is a wholly owned subsidiary of Jefferies Financial Group Inc. (NYSE: JEF), a diversified financial services company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200528005663/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 08:50:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 08:30:00 CET | Press release
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committ
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 08:00:00 CET | Press release
The project confirms NHOA Energy’s long-term commitment to the Italian market NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 02:18:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
Andersen Consulting udvider sine kompetencer inden for ledelsesrekruttering med Lansdowne Executive Search18.2.2026 17:08:00 CET | Pressemeddelelse
Andersen Consulting styrker sin humancapital-praksis gennem en samarbejdsaftale med Lansdowne Executive Search, der er en Dublin-baseret virksomhed med speciale i lederrekruttering, midlertidige ledelser og bestyrelsesudnævnelser. Lansdowne Executive Search er en irisk-ejet virksomhed, der blev grundlagt i 2015, og som tilbyder C-level-ledelsesekruttering, deltidsledere og bestyrelsesplaceringer. Som en partnerdrevet boutique-virksomhed er Lansdowne kendt for, at seniorledelsen er tæt involveret i alle kundeprojekter. Virksomheden hjælper kunder med at navigere i komplekse ledelsesovergange og vækststrategier på tværs af en bred vifte af sektorer, herunder finans, byggeindustrien, nonprofit, landbrug, videregående uddannelse, den offentlige sektor samt teknologi, medier og telekommunikation. "God ledelse er afhænger af situationen, og det kræver forståelse af langt mere end blot et CV," sagde Tom Keane, der er partner hos Lansdowne Executive Search. "Samarbejdet med Andersen Consulting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
